Approaches to Assessing the Rationality of Drug Usage in a Developed Country
- 24 April 2009
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 222 (S721) , 21-26
- https://doi.org/10.1111/j.0954-6820.1987.tb05373.x
Abstract
The prerequisites for analyses of the medical, social and economic consequences of drug usage are in part available in Sweden. Hard data, though, are still fragmentary. Examples are given where various data sources and methods have been applied. It is suggested that feedback of drug utilization data should increase to create a more questioning attitude among prescribers. The concept of medical audit has to be better explained including the fact that individual-based registers are necessary tools in trying to assess the rationality of drug treatment. In the future such analyses should focus on everyday treatment of common disease entities such as hypertension, diabetes, dyspepsia and asthma. Long term medical and economical consequences of optimized pharmacological versus non-pharmacological treatment should be studied.Keywords
This publication has 6 references indexed in Scilit:
- Prescription drug use among diabetics—A population studyJournal of Chronic Diseases, 1987
- Continuous recording of drug prescribing in Sweden 1974–1983. Methods and examples of utilization of dataEuropean Journal of Clinical Pharmacology, 1987
- Absence of Therapeutic Benefit from Antacids or Cimetidine in Non-Ulcer DyspepsiaNew England Journal of Medicine, 1986
- The Clinical Diagnosis of ‘Gastritis’Scandinavian Journal of Gastroenterology, 1984
- Epidemiology of adverse drug reactions to phenformin and metformin.BMJ, 1978
- Recording of drug prescriptions in the county of Jämtland, SwedenEuropean Journal of Clinical Pharmacology, 1977